Pierson D, Bandel C, Ehrig T, et al. Benign epidermal tumors and proliferations. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. London: Mosby; 2003:597-602.
MacKie RM, Quinn AG. Non-melanoma skin cancer and other epidermal skin tumors. In: Burns T, Breathnach SM, Cox N, et al, eds. Rook's textbook of dermatology. 7th ed. Oxford, UK: Blackwell; 2004:36-45.
Weedon D. Chapter 31: Tumors of the epidermis. In: Weedon D. Skin pathology. 2nd ed. London: Churchill Livingstone; 2002:765-771.
Altmeyer P, Bacharach-Buhles M, eds. Enzyklopadie dermatologie, allergologie, umweltmedizin. Berlin: Springer; 2002.
Ortonne JP, Pandya AG, Lui H, et al. Treatment of solar lentigines. J Am Acad Dermatol. 2006;54(suppl 2):S262-S271.
Krupashankar DS; IADVL Dermatosurgery Task Force. Standard guidelines of care: CO2 laser for removal of benign skin lesions and resurfacing. Indian J Dermatol Venereol Leprol. 2008;74(suppl):S61-S67.
1. Pierson D, Bandel C, Ehrig T, et al. Benign epidermal tumors and proliferations. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. London: Mosby; 2003:597-602.
2. MacKie RM, Quinn AG. Non-melanoma skin cancer and other epidermal skin tumors. In: Burns T, Breathnach SM, Cox N, et al, eds. Rook's textbook of dermatology. 7th ed. Oxford, UK: Blackwell; 2004:36-45.
3. Weedon D. Chapter 31: Tumors of the epidermis. In: Weedon D. Skin pathology. 2nd ed. London: Churchill Livingstone; 2002:765-771.
4. Altmeyer P, Bacharach-Buhles M, eds. Enzyklopadie dermatologie, allergologie, umweltmedizin. Berlin: Springer; 2002.
5. Yeatman JM, Kilkenny M, Marks R. The prevalence of seborrhoeic keratoses in an Australian population: does exposure to sunlight play a part in their frequency? Br J Dermatol. 1997;137:411-414.
6. Reiches AJ. Seborrheic keratoses: are they delayed hereditary nevi? AMA Arch Dermatol Syphilol. 1952;65:596-600.
7. Kwon OS, Hwang EJ, Bae JH, et al. Seborrheic keratosis in the Korean males: causative role of sunlight. Photodermatol Photoimmunol Photomed. 2003;19:73-80.
8. Hafner C, Hartmann A, van Oers JM, et al. FGFR3 mutations in seborrheic keratoses are already present in flat lesions and associated with age and localization. Mod Pathol. 2007;20:895-903.
9. Lee ES, Whang MR, Kang WH. Absence of human papillomavirus DNA in nongenital seborrheic keratosis. J Korean Med Sci. 2001;16:619-622.
10. Bafounta ML, Beauchet A, Aegerter P, et al. Is dermoscopy (epiluminescence microscopy) useful for the diagnosis of melanoma? Results of a meta-analysis using techniques adapted to the evaluation of diagnostic tests. Arch Dermatol. 2001;137:1343-1350.
11. Braun RP, Rabinovitz HS, Krischer J, et al. Dermoscopy of pigmented seborrheic keratosis: a morphological study. Arch Dermatol. 2002;138:1556-1560.
12. Wang SQ, Rabinovitz H, Oliviero MC. Dermoscopic patterns of solar lentigines and seborrheic keratoses. Braun. In: Marghoob AA, Braun RP, Kopf AW, eds. Atlas of dermoscopy. London: Taylor and Francis; 2005:60-71.
13. Ahlgrimm-Siess V, Cao T, Oliviero M, et al. Seborrheic keratosis: reflectance confocal microscopy features and correlation with dermoscopy. J Am Acad Dermatol. 2013;69:120-126.
14. Izikson L, Sober AJ, Mihm MC Jr, et al. Prevalence of melanoma clinically resembling seborrheic keratosis: analysis of 9204 cases. Arch Dermatol. 2002;138:1562-1566.
15. Carucci J, Leffell DJ. Basal cell carcinoma. In: Freedberg IM, Eisen AZ, Wolff K, et al. Fitzpatrick's dermatology in general medicine. New York, NY: McGraw-Hill; 2003:747-754.
16. Holdiness MR. On the classification of the sign of Leser-Trelat. J Am Acad Dermatology. 1988;19:754-757.
17. Schwartz RA. Sign of Leser-Trelat. J Am Acad Dermatol. 1996;35:88-95.
18. Motley RJ. Seborrheic keratosis. In: Lebwohl MG, Heymann WR, Berth-Jones J, et al, eds. Treatment of skin disease. Comprehensive therapeutic strategies. London: Mosby; 2006:609-610.
19. Wood LD, Stucki JK, Hollenbeak CS, et al. Effectiveness of cryosurgery vs curettage in the treatment of seborrheic keratoses. JAMA Dermatol. 2013;149:108-109.
20. Ortonne JP, Pandya AG, Lui H, et al. Treatment of solar lentigines. J Am Acad Dermatol. 2006;54(suppl 2):S262-S271.
21. Krupashankar DS; IADVL Dermatosurgery Task Force. Standard guidelines of care: CO2 laser for removal of benign skin lesions and resurfacing. Indian J Dermatol Venereol Leprol. 2008;74(suppl):S61-S67.
22. Polder KD, Landau JM, Vergilis-Kalner IJ, et al. Laser eradication of pigmented lesions: a review. Dermatol Surg. 2011;37:572-595.
23. Brodsky J. Management of benign skin lesions commonly affecting the face: actinic keratosis, seborrheic keratosis, and rosacea. Curr Opin Otolaryngol Head Neck Surg. 2009;17:315-320.
24. Cuevas P, Angulo J, Salgüero I, et al. Clearance of seborrhoeic keratoses with topical dobesilate. BMJ Case Rep. 2012;pii:bcr0120125628.
25. Baumann LS, Blauvelt A, Draelos ZD, et al. Safety and efficacy of hydrogen peroxide topical solution, 40% (w/w), in patients with seborrheic keratoses: Results from 2 identical, randomized, double-blind, placebo-controlled, phase 3 studies (A-101-SEBK-301/302). J Am Acad Dermatol. 2018 Jun 1;79(5):869-877.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台